Consequences of Covid-19 on the Psychological and Physical Health of the Nursing Staff and on Their Professional Activity.

The Consequences of Covid-19 on the Psychological and Physical Health of the Nursing Staff of the Hospital of Villeneuve Saint Georges and on Their Professional Activity. (SST-Covid Impact)

The aim of this research is to identify the consequences of the Covid-19 on the physical and psychological health of the nursing staff of the Intercommunal Hospital of Villeneuve-Saint-Georges and on their professional activity thanks to a self-questionnaire.

This anonymous self-questionnaire is intended for all the CHIV care workers who were infected by the coronavirus during the first wave and identified by the occupational health service.

Study Overview

• Status: Completed
• Conditions: Work-related Illness
• Intervention / Treatment: Other: Self-questionnaire

Detailed Description

The covid-19 pandemic has had an important impact in the world, in France, it has put our health system under tension. We know that a health crisis of this magnitude can induce psychological and physical disorders, particularly in exposed caregivers.

Systematic occupational medicine consultations of all medical and paramedical personnel, whether tenured or not, working at the Villeneuve Saint Georges Hospital (CHIV) who presented a Covid-19 between February 1 and June 30, 2020, allowed us to note the presence of multiple after-effects.

The present study evaluates the consequences of the disease on the physical and psychological health of these caregivers and on their professional activity.

• Study Type: Observational
• Enrollment (Actual): 50

Contacts and Locations

Study Locations

• France
  • IDF
    • Villeneuve-Saint-Georges, IDF, France, 94190
      • Centre Hospitalier Intercommunal de Villeneuve-Saint-Georges

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Health care population (medical and paramedical) practicing at the Centre Hospitalier Intercommunal de Villeneuve-Saint-Georges, having been reached by the Covid-19 during the first wave, between February 1st and June 30th 2020.

Description

Inclusion Criteria:

1. Major patient
2. Part of the medical and paramedical staff working at the CHIV,
3. Having been reached by Covid-19 during the first wave, between February 1st and June 30th 2020.
4. Patient affiliated to a social security system

Exclusion Criteria:

• None

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Physical and psychological health	Percentage of physical and psychological after-effects	up to 1 month

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Recognized occupational diseases	Number of recognized occupational diseases	up to 1 month
Days of sick leave	Evaluate the number of days of sick leave.	up to 1 month
Reclassifications	Evaluate the number of reclassifications	up to 1 month
workstation adjustments	Evaluate the number workstation adjustments	up to 1 month
Repercussions on the professional activity	The existence of repercussions on the professional activity	up to 1 month

Collaborators and Investigators

• Sponsor: Centre Hospitalier Intercommunal Creteil

Study record dates

Study Major Dates

• Study Start (Actual): September 3, 2021
• Primary Completion (Actual): March 15, 2022
• Study Completion (Actual): April 28, 2022

Study Registration Dates

• First Submitted: August 10, 2021
• First Submitted That Met QC Criteria: August 10, 2021
• First Posted (Actual): August 11, 2021

Study Record Updates

• Last Update Posted (Actual): August 18, 2022
• Last Update Submitted That Met QC Criteria: August 17, 2022
• Last Verified: August 1, 2022

More Information

Terms related to this study

• Other Study ID Numbers: SST-Covid Impact

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No